BOD Australia climbs on first purchase order for U.S. market

Bod Science

07/04/2021 02:30

** BOD Australia Ltd  BDA.AX  rises as much as 7.4% to
A$0.510, hitting its highest since March 26
    ** Cannabis-focused healthcare co says it receives its first
binding purchase order from exclusive global partner Health &
Happiness Group for CBD products for the U.S. market
 urn:newsml:reuters.com:*:nASX9z3QyB
    ** BDA says more purchase orders for the U.S. market are
expected, with co fully funded for product manufacturing
requirements
    ** Stock posts its biggest intraday percentage gain in a
week
    ** More than 456,000 shares change hands, compared with the
30-day average volume of about 399,000
    ** Stock down 3.1% this year, as of last close

 (Reporting by Rashmi Ashok in Bengaluru)
 ((Rashmi.Ashok@thomsonreuters.com; +918061822604;))